A genetically defined normal human somatic cell system to study ras oncogenesis in vivo and in vitro

Kevin M O'Hayer1, Christopher M Counter

  • 1Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina, USA.

Insights

This study introduces a novel method to investigate Ras oncogenesis in genetically defined human cells. This system enables the dissection of Ras pathways and tumor growth requirements in human cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Transgenic mice, murine cells, and human cancer cell lines are common models for studying Ras oncogenesis.
  • However, these models have limitations in studying Ras function within genetically defined human cells.

Purpose of the Study:

  • To develop a system for studying Ras function in genetically defined human cells.
  • To enable the dissection of Ras requirements for tumor formation and growth pathways in human cells.

Main Methods:

  • Creation of stable human somatic cell lines expressing SV-40 T/t antigens, human telomerase reverse transcriptase (hTERT), and Ras.
  • Utilizing these cell lines for soft agar and xenograft tumor formation assays.

Main Results:

  • Ras is essential for tumor formation in normal human somatic cells engineered with specific oncogenic and tumor-suppressor-inactivating factors.
  • The developed system allows for the analysis of Ras function in matched cells across different species and tissues.

Conclusions:

  • This novel system provides a valuable tool for understanding Ras oncogenesis in human cells.
  • It facilitates the detailed study of individual pathways contributing to tumor development.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...